[Federal Register Volume 76, Number 75 (Tuesday, April 19, 2011)]
[Notices]
[Pages 21907-21908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-9418]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2011-0002]
Draft Action Plan--A Public Health Action Plan To Combat
Antimicrobial Resistance
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (DHHS).
ACTION: Extension of public comment period.
-----------------------------------------------------------------------
SUMMARY: On March 16, 2011, the Centers for Disease Control and
Prevention (CDC), located within the Department of Health and Human
Services (HHS) published a notice in the Federal Register requesting
public comment on the draft, A Public Health Action Plan to Combat
Antimicrobial Resistance (76 FR 14402). Written and electronic comments
were to be received on or before April 15, 2011. CDC/HHS received
requests asking for a 60-day extension of the comment period. In
consideration of those requests, HHS/CDC is extending the comment
period by 60 days to June 14, 2011.
DATES: Written or electronic comments must be received on or before
June 14,
[[Page 21908]]
2011. Please refer to SUPPLEMENTARY INFORMATION for additional
information.
ADDRESSES: Written comments may be submitted to the following address:
Centers for Disease Control and Prevention, National Center for
Emerging and Zoonotic Infectious Diseases, Division of Healthcare
Quality Promotion, Office of Antimicrobial Resistance, Attn:
Antimicrobial Resistance Action Plan, Docket No. CDC-2011-0002, 1600
Clifton Rd., NE., Mailstop A-07, Atlanta, Georgia 30333.
You may also submit written comments electronically to: http://www.regulations.gov. All comments received will be posted publicly
without change, including any personal or proprietary information
provided. To download an electronic version of the plan, access http://www.regulations.gov.
Written comments, identified by Docket No. CDC-2011-0002 will be
available for public inspection Monday through Friday, except for legal
holidays, from 9 a.m. until 5 p.m., Eastern Daylight Time, at 1600
Clifton Road, NE., Atlanta, Georgia 30333. Please call ahead to (404)
639-4000 and ask for a representative from the Office of Antimicrobial
Resistance to schedule your visit. Comments may also be viewed at
http://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Rachel Wolf, Centers for Disease
Control and Prevention, National Center for Emerging and Zoonotic
Infectious Diseases, Division of Healthcare Quality Promotion, Office
of Antimicrobial Resistance; 1600 Clifton Road, NE., Mailstop A-07,
Atlanta, Georgia 30333. (404) 639-4000.
SUPPLEMENTARY INFORMATION: The HHS Interagency Task Force on
Antimicrobial Resistance (hereafter referred to as the Task Force) was
created in 1999 to coordinate the activities of Federal agencies in
addressing antimicrobial resistance (AR) in recognition of the
increasing importance of AR as a public health threat. The Task Force
is co-chaired by the Centers for Disease Control and Prevention (CDC),
the Food and Drug Administration (FDA), and the National Institutes of
Health (NIH). The Task Force also includes the Agency for Healthcare
Research and Quality (AHRQ), the Centers for Medicare and Medicaid
Services (CMS), the Health Resources and Services Administration
(HRSA), the HHS Office of the Assistant Secretary for Preparedness and
Response (HHS/ASPR), the Department of Agriculture (USDA), the
Department of Defense (DoD), the Department of Veterans Affairs (VA),
and the Environmental Protection Agency (EPA).
In 2001, the Task Force developed an initial Action Plan, outlining
specific issues, goals, and actions important for addressing the
problem of AR. This document, entitled, A Public Health Action Plan to
Combat Antimicrobial Resistance, Part I: Domestic Issues, reflected a
broad-based consensus of participating Federal agencies, which was
reached with individual input from state and local health agencies,
universities, professional societies, pharmaceutical companies,
healthcare delivery organizations, agricultural producers, consumer
groups, and other members of the public. Continued collaboration with
these partners has been vital to achieving successful implementation of
the Action Plan.
This draft document, A Public Health Action Plan to Combat
Antimicrobial Resistance, is a revision of the 2001 interagency action
plan. The revised Action Plan provides an updated blueprint for
specific, coordinated Federal action to address emerging threats in AR.
The document covers a broad spectrum of AR issues, addressing
resistance in a wide range of pathogens (bacteria, viruses, fungi, and
parasites) and settings (human medicine, veterinary medicine,
agriculture, animal production, and others).
The Action Plan includes action items organized into four focus
areas: Surveillance, Prevention and Control, Research, and Product
Development. The Action Plan contains specific action items, projects,
and implementation steps. Wherever possible, action items are populated
with specific projects or implementation steps to provide greater
specificity for planned Federal activities. The action items, projects,
and implementation steps do not represent an exhaustive list of
activities.
HHS/CDC has posted the original notice and all related materials on
http://www.regulations.gov.
Dated: April 13, 2011.
John Murphy,
Business Operation Manager, Centers for Disease Control and Prevention.
[FR Doc. 2011-9418 Filed 4-18-11; 8:45 am]
BILLING CODE 4163-18-P